Palvella Therapeutics, Inc. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-04: Form 10-Q; Exhibit 10.2; Description Form of Notice of Grant of Performance-Based Restricted Stock Unit Award under the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan..
- 2026-06-16: Form 8-K; Exhibit 10.1; Description Amendment No. 1 to the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan.
- 2026-03-31: Form 10-K; Exhibit 10.30; Description Office Building Lease, dated October 1, 2025, by and between LMP 353, LLC and Palvella Therapeutics, Inc..
- 2025-08-14: Form 10-Q; Exhibit 10.2; Description Severance Agreement, dated May 21, 2025, by and between Ashley Kline and Palvella Therapeutics, Inc..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-04 | 10-Q | 10.2 | Form of Notice of Grant of Performance-Based Restricted Stock Unit Award under the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan. |
|---|
| 2026-06-16 | 8-K | 10.1 | Amendment No. 1 to the Palvella Therapeutics, Inc. 2024 Equity Incentive Plan |
|---|
| 2026-03-31 | 10-K | 10.30 | Office Building Lease, dated October 1, 2025, by and between LMP 353, LLC and Palvella Therapeutics, Inc. |
|---|